Skip to main content
. 2021 Oct 11;118(43):e2108728118. doi: 10.1073/pnas.2108728118

Fig. 7.

Fig. 7.

(A) Inhibition of the cytopathic effects (viral toxicity) of wild-type SARS-CoV-2 Calu-3 by lead TMPRSS2 inhibitors using the CellTiter-Glo (Promega) assay. (B) Viability of Calu-3 cells with compounds in the absence of virus (compound toxicity).